| Galit Alter | |
| Birth Date: | [1] |
| Fields: | immunology, infectious diseases |
| Workplaces: | Harvard Medical School Ragon Institute |
| Education: | Ph.D. from McGill University[2] |
| Thesis1 Title: | and |
| Thesis2 Title: | )--> |
| Thesis1 Url: | and |
| Thesis2 Url: | )--> |
| Thesis1 Year: | and |
| Thesis2 Year: | )--> |
| Doctoral Advisors: | )--> |
| Awards: | MGH Research Scholars Award (twice)[3] |
Galit Alter is an immunologist and virologist, professor of medicine at Harvard Medical School, and group leader at the Ragon Institute of MGH, MIT and Harvard. She is known for her work on the expansion of particular natural killer cell subtypes in response to HIV-1 infection.[4] [5] She has also contributed to the understanding of how SARS-CoV-2 antibody titers correlate with sustained humoral protection, including identifying coordinated immune cell-antibody signatures that may predict COVID-19 infection outcome.[1] [6]
In October 2022 she became Vice President of Immunology in Infectious Disease Research at Moderna[7]